問卷

TPIDB > Search Result > Clinical Trials List

Clinical Trials List

Protocol NumberFENG-NAV-202
Not yet recruiting

2025-11-19 - 2030-06-30

Phase II

Recruiting10

ICD-10C57.4

Malignant neoplasm of uterine adnexa, unspecified

ICD-10Z51.12

Encounter for antineoplastic immunotherapy

ICD-9183.8

Malignant neoplasm of other specified sites of uterine adnexa

  • Sponsor

  • Trial scale

    Taiwan Multiple Center

  • Update

    2026/02/01

Investigators and Locations

Principal Investigator 陳楨瑞 Division of Obstetrics & Gynecology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator Peng-Hui Wang Division of Obstetrics & Gynecology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator Lian-Shung Yeh Division of Obstetrics & Gynecology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator 余慕賢 Division of Obstetrics & Gynecology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator Chien-Hsing Lu Division of Obstetrics & Gynecology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator 周宏學 Division of Obstetrics & Gynecology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator 陳子和 Division of Obstetrics & Gynecology

Co-Principal Investigator

  • 林子棋 Division of Obstetrics & Gynecology
  • 簡宏如 Division of Obstetrics & Gynecology
  • 林炫聿 Division of Hematology & Oncology
  • 曾若涵 Division of Hematology & Oncology
  • 賴冠銘 Division of Hematology & Oncology

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator 蕭聖謀 Division of Obstetrics & Gynecology

Co-Principal Investigator

  • 吳文毅 Division of Obstetrics & Gynecology
  • 陳惠華 Division of Obstetrics & Gynecology
  • 魏銘洲 Division of Obstetrics & Gynecology
  • 孫序東 Division of Obstetrics & Gynecology
  • 陳奐樺 Division of Obstetrics & Gynecology

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator Tzu-I Wu Division of Obstetrics & Gynecology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator 曾志仁​ Division of Obstetrics & Gynecology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Condition/Disease

Objectives

Test Drug

Active Ingredient

Dosage Form

Dosage

Endpoints

Inclution Criteria

The Estimated Number of Participants

  • Taiwan

    60 participants

  • Global

    60 participants